Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.880
-0.220 (-7.10%)
At close: Jan 2, 2026, 4:00 PM EST
2.937
+0.057 (1.99%)
Pre-market: Jan 5, 2026, 8:00 AM EST
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $666.59 million as of January 5, 2026. Its market cap has increased by 242.93% in one year.
Market Cap
666.59M
Enterprise Value
689.25M
1-Year Change
242.93%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $666.59M, a decrease of -33.02%. That is a compound annual growth rate of -5.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 666.59M | -7.10% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |